Study suggests aspirin may reduce risk of melanoma
A new Stanford University study suggests taking aspirin may reduce the risk of melanoma in women.
Researchers looked at nearly 60,000 postmenopausal women for 12 years in the largest study of its kind. They found the women who took regular doses of aspirin lowered their risk of getting melanoma by at least 20 percent.
Researchers believe inflammation plays a big role in cancer development and aspirin is an anti-inflammatory drug. But they caution that an aspirin a day won't keep melanoma away.
The study can be found in the journal Cancer.
stanford university, cancer, medical research, health
- Suspect in San Francisco police shooting arrested
- Pedestrian fatally struck by SUV on NB Highway 880
- PM: Won't budge '1 centimeter' from Ukrainian land
- Missing 11-year-old boy Bryan Lazo found
- Fatal collision blocks lanes on I-880 near Coliseum 45 min ago
- Immigration detainees continue hunger strike
- Teenage boy killed trying to walk across Highway 85
- Tucson courting car maker Tesla for 6,500 jobs
- Wolff: Temporary baseball stadium for A's possible
- '300' sequel rules box office with $45.1M debut
- Toddler uses FaceTime to save mom after dog attack
- Wheel of Fortune is in Northern California!
- weather: Bay Area weather forecast for Sunday
- roundup: Fatal bar shooting; Utility truck thefts